Aclaris Therapeutics Supports Investigator-Initiated Clinical Trial of ATI-450 for Cytokine Release Syndrome in Hospitalized Patients with COVID-19

NEXT STORY
Innovation Pharmaceuticals’ Brilacidin Inhibits SARS-CoV-2 (COVID-19) by 97 Percent in a Human Lung Cell Line
PREV STORY
Brain Scientific Updates Disposable EEG Headset Sales Plan, Supply Scale-Up, and IP Status
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

AzurRx BioPharma Announces Completion of Enrollment in Phase 2b OPTION 2 Clinical Trial of MS1819 in Cystic Fibrosis

author_avatar
NASDAQ Market News

Clearside Biomedical Enters into Strategic Collaboration with EyeKor to Support Clinical Development Efforts

ALPHARETTA, Ga. and MADISON, Wis., March 31, 2017 (GLOBE NEWSWIRE) -- Clearside Biomedical Inc. ...

author_avatar
NASDAQ Market News

Vir Biotechnology Announces Initiation of Phase 1 Clinical Trial to Evaluate a Novel Vaccine Platform

author_avatar
NASDAQ Market News